Abstract:Cationic lipids can easily assemble into spherical liposomes in aqueous phase which showed unique superiority in drug and gene delivery. However, the toxicity of cationic lipids is still an obstacle to application. To develop low toxicity cationic lipids, we designed two cationic lipids contained different number of hydroxyl groups. Biocompatible mono-hydroxyl and multi-hydroxyl galactose head group was respectively modified to a biodegradable quaternary amine lipid, and two novel hydroxyl cationic lipids were synthesized and characterized by MS, 1H NMR and 13C NMR. Two lipids showed good surface activity and both of them can assemble to about 80 nm stable small unilamellar vesicles (SUVs) with cholesterol in aqueous phase. Both of lipids showed relatively lower toxicity than the well-known cationic lipid 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP). In vitro 24 h IC50 of two assemblies were more than 50 μg/mL, which were about 10 μg/mL higher than the IC50 of DOTAP. Multi-hydroxyl galactose lipids group showed much lower toxicity than mono-hydroxyl lipids group. Moreover, Both of the assemblies with lower hemolysis were nearly non-hemolytic risk under the concentration of 30 μg/mL. Transmission electron microscopy (TEM) and dynamic light scattering (DLS) showed that the average sizes of both doxorubicin (DOX) loaded liposomes were about 110 nm. The DOX entrapment efficiencies of galactose liposome and mono-hydroxyl liposome were 58% and 91%, respectively. Both of the DOX loaded liposomes were stable after one month placed at room temperature. Two DOX loaded liposomes showed better anti-cancer effect than free DOX above 5 μg/mL, and they can be internalized into cells and produce more release of DOX inside MCF-7 cells and HepG2 cells at pH 5.0. These results suggested that synthesized lipids are suitable as potential low toxicity cationic drug delivery systems.

Synthesis and Characterization of Novel Cationic Lipids Derived from Thio Galactose

Synthesis and Characterization of a New Cationic Galactolipid with Carbamate for Gene Delivery

Preparation and Biological Property Evaluation of Novel Cationic Lipid-Based Liposomes for Efficient Gene Delivery

Cationic lipids containing cyclen and ammonium moieties as gene delivery vectors.

Synthesis and characterization of a series of carbamate-linked cationic lipids for gene delivery

Synthesis of Cationic Lipids Containing Bis-cyclen Units and Interaction with DNA

TACN-based cationic lipids with amino acid backbone and double tails: materials for non-viral gene delivery.

Synthesis and Characterization of Carbamate-Linked Cationic Lipids with Hydroxyethyl Group

Synthesis And Gene Transfection Activity Of Cyclen-Based Cationic Lipids With Asymmetric Acyl-Cholesteryl Hydrophobic Tails

Cationic lipids with a cyclen headgroup: synthesis and structure–activity relationship studies as non-viral gene vectors

Cyclen-Based Cationic Lipids: Design, Synthesis and Interactions with Dna

Cationic Lipids Containing Protonated Cyclen and Different Hydrophobic Groups Linked by Uracil-Pna Monomer: Synthesis and Application for Gene Delivery.

Cyclen-based cationic lipids with double hydrophobic tails for efficient gene delivery

Synthesis and evaluation of mono- and multi-hydroxyl low toxicity pH-sensitive cationic lipids for drug delivery.

Novel imidazole-functionalized cyclen cationic lipids: synthesis and application as non-viral gene vectors.

Design, Synthesis and Gene Transfection Activity of Macrocyclic Polyamine-Imidazolium Based Cationic Lipids

Synthesis and Characterization of Long Chain Alkyl Acyl Carnitine Esters. Potentially Biodegradable Cationic Lipids for Use in Gene Delivery

Synthesis and characterizations of cationic lipid molecules for siRNA delivery

Cholesterol-based Cationic Lipids for Gene Delivery: Contribution of Molecular Structure Factors to Physico-Chemical and Biological Properties

Synthetic diether-linked cationic lipids for gene delivery